Differential support of cell adhesion and growth by copolymers of polyurethane with hyaluronic acid

Journal of Biomedical Materials Research - Part A

Volumn 101, Issue 10, 2013, Pages 2870-2882

  Ruiz, Amaliris ^a   Flanagan, Claire E ^a   Masters, Kristyn S ^a  

^a University of Wisconsin Madison   (United States)

Author keywords

electrospinning; endothelialization; hemocompatibility; hyaluronic acid; polyurethane

Indexed keywords

BACTERICIDAL ACTIVITY; BIOLOGICAL PROPERTIES; ENDOTHELIALIZATION; HEMOCOMPATIBILITY; MACROPHAGE PROLIFERATION; SMALL DIAMETER VASCULAR GRAFTS; SYNTHETIC VASCULAR GRAFT; TWO DIMENSIONAL (2 D);

BIOLOGICAL MATERIALS; CELL ADHESION; CELL CULTURE; ELECTROSPINNING; ENDOTHELIAL CELLS; FIBROBLASTS; FILMS; GRAFTS; GROWTH (MATERIALS); ORGANIC ACIDS; POLYURETHANES;

HYALURONIC ACID;

BIOMATERIAL; HYALURONIC ACID; POLYURETHAN;

ANIMAL CELL; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM ADHERENCE; BIOLOGICAL ACTIVITY; BLOOD VESSEL GRAFT; CELL ADHESION; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; MACROPHAGE; MOLECULAR WEIGHT; NONHUMAN; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE ADHESION;

ELECTROSPINNING; ENDOTHELIALIZATION; HEMOCOMPATIBILITY; HYALURONIC ACID; POLYURETHANE;

ADSORPTION; ANIMALS; CATTLE; CELL ADHESION; CELL COMMUNICATION; CELL COUNT; CELL PROLIFERATION; DNA; ENDOTHELIAL CELLS; FIBROBLASTS; HUMANS; HYALURONIC ACID; MACROPHAGES; MATERIALS TESTING; MECHANICAL PHENOMENA; MICE; MOLECULAR WEIGHT; NIH 3T3 CELLS; POLYURETHANES; PROTEINS; SURFACE PROPERTIES; TISSUE SCAFFOLDS; U937 CELLS;

EID: 84883246927     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34597     Document Type: Article

References (66)

1. Epstein AJ, Polsky D, Yang F, Yang L, Groeneveld PW,. Coronary revascularization trends in the United States, 2001-2008. JAMA 2011; 305 (17): 1769-1776.
2. Veith FJ, Moss CM, Sprayregen S, Montefusco C,. Preoperative saphenous venography in arterial reconstructive surgery of the lower extremity. Surgery 1979; 85 (3): 253-256.
3. Bergan JJ, Veith FJ, Bernhard VM, Yao JS, Flinn WR, Gupta SK, Scher LA, Samson RH, Towne JB,. Randomization of autogenous vein and polytetrafluorethylene grafts in femoral-distal reconstruction. Surgery 1982; 92 (6): 921-930.
4. Kannan RY, Salacinski HJ, Butler PE, Hamilton G, Seifalian AM,. Current status of prosthetic bypass grafts: A review. J Biomed Mater Res B Appl Biomater 2005; 74 (1): 570-581.
5. Ratcliffe A,. Tissue engineering of vascular grafts. Matrix Biol 2000; 19 (4): 353-357.
6. Xue L, Greisler HP,. Biomaterials in the development and future of vascular grafts. J Vasc Surg 2003; 37 (2): 472-480.
7. Salacinski HJ, Goldner S, Giudiceandrea A, Hamilton G, Seifalian AM, Edwards A, Carson RJ,. The mechanical behavior of vascular grafts: A review. J Biomater Appl 2001; 15 (3): 241-278.
8. Darouiche RO,. Treatment of infections associated with surgical implants. N Engl J Med 2004; 350 (14): 1422-1429.
9. Pottecher T, Forrler M, Picardat P, Krause D, Bellocq JP, Otteni JC,. Thrombogenicity of central venous catheters: Prospective study of polyethylene, silicone and polyurethane catheters with phlebography or post-mortem examination. Eur J Anaesthesiol 1984; 1 (4): 361-365.
10. Tsutsui T, Imamura E, Kayanagi H,. The development of nonstended trileaflet valve prosthesis. Artif Organs 1981; 10: 590-593.
11. Devanathan T, Sluetz JE, Young KA,. In vivo thrombogenicity of implantable cardiac pacing leads. Biomater Med Devices Artif Organs 1980; 8 (4): 369-379.
12. Giudiceandrea A, Seifalian AM, Krijgsman B, Hamilton G,. Effect of prolonged pulsatile shear stress in vitro on endothelial cell seeded PTFE and compliant polyurethane vascular grafts. Eur J Vasc Endovasc Surg 1998; 15 (2): 147-154.
13. Grasel TG, Cooper SL,. Surface properties and blood compatibility of polyurethaneureas. Biomaterials 1986; 7 (5): 315-328.
14. Ito Y, Sisido M, Imanishi Y,. Synthesis and antithrombogenicity of anionic polyurethanes and heparin-bound polyurethanes. J Biomed Mater Res 1986; 20 (8): 1157-1177.
15. Okkema AZ, Cooper SL,. Effect of carboxylate and/or sulphonate ion incorporation on the physical and blood-contacting properties of a polyetherurethane. Biomaterials 1991; 12 (7): 668-676.
16. Krijgsman B, Seifalian AM, Salacinski HJ, Tai NR, Punshon G, Fuller BJ, Hamilton G,. An assessment of covalent grafting of RGD peptides to the surface of a compliant poly(carbonate-urea) urethane vascular conduit versus conventional biological coatings: Its role in enhancing cellular retention. Tissue Eng 2002; 8 (4): 673-680.
17. Zhu Y, Gao C, He T, Shen J,. Endothelium regeneration on luminal surface of polyurethane vascular scaffold modified with diamine and covalently grafted with gelatin. Biomaterials 2004; 25 (3): 423-430.
18. De S, Sharma R, Trigwell S, Laska B, Ali N, Mazumder MK, Mehta JL,. Plasma treatment of polyurethane coating for improving endothelial cell growth and adhesion. J Biomater Sci Polym Ed 2005; 16 (8): 973-989.
19. Lee JH, Lee HB,. Platelet adhesion onto wettability gradient surfaces in the absence and presence of plasma proteins. J Biomed Mater Res 1998; 41 (2): 304-311.
20. Werner C, Maitz MF, Sperling C,. Current strategies towards hemocompatible coatings. J Mater Chem 2007; 17 (32): 3376-3384.
21. Sperling C, Schweiss RB, Streller U, Werner C,. In vitro hemocompatibility of self-assembled monolayers displaying various functional groups. Biomaterials 2005; 26 (33): 6547-6557.
22. Amarnath LP, Srinivas A, Ramamurthi A,. In vitro hemocompatibility testing of UV-modified hyaluronan hydrogels. Biomaterials 2006; 27 (8): 1416-1424.
23. Siegelman MH, DeGrendele HC, Estess P,. Activation and interaction of CD44 and hyaluronan in immunological systems. J Leukoc Biol 1999; 66 (2): 315-321.
24. West DC, Hampson IN, Arnold F, Kumar S,. Angiogenesis induced by degradation products of hyaluronic acid. Science 1985; 228 (4705): 1324.
25. Pirnazar P, Wolinsky L, Nachnani S, Haake S, Pilloni A, Bernard GW,. Bacteriostatic effects of hyaluronic acid. J Periodontol 1999; 70 (4): 370-374.
26. West DC, Kumar S,. The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. Exp Cell Res 1989; 183 (1): 179-196.
27. Entwistle J, Hall CL, Turley EA,. HA receptors: Regulators of signalling to the cytoskeleton. J Cell Biochem 1996; 61 (4): 569-577.
28. Chen WY, Abatangelo G,. Functions of hyaluronan in wound repair. Wound Repair Regen 1999; 7 (2): 79-89.
29. Morra M,. Engineering of biomaterials surfaces by hyaluronan. Biomacromolecules 2005; 6 (3): 1205-1223.
30. Feinberg RN, Beebe DC,. Hyaluronate in vasculogenesis. Science 1983; 220 (4602): 1177-1179.
31. Goldberg RL, Toole BP,. Hyaluronate inhibition of cell proliferation. Arthritis Rheum 1987; 30 (7): 769-778.
32. Mast BA, Diegelmann RF, Krummel TM, Cohen IK,. Hyaluronic acid modulates proliferation, collagen and protein synthesis of cultured fetal fibroblasts. Matrix 1993; 13 (6): 441-446.
33. Roy-Chaudhury P, Wang Y, Krishnamoorthy M, Zhang J, Banerjee R, Munda R, Heffelfinger S, Arend L,. Cellular phenotypes in human stenotic lesions from haemodialysis vascular access. Nephrol Dial Transplant 2009; 24 (9): 2786-2791.
34. Shi Y, O'Brien JE, Fard A, Mannion JD, Wang D, Zalewski A,. Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation 1996; 94 (7): 1655-1664.
35. Chuang TW, Masters KS,. Regulation of polyurethane hemocompatibility and endothelialization by tethered hyaluronic acid oligosaccharides. Biomaterials 2009; 30 (29): 5341-5351.
36. Xu F, Nacker JC, Crone WC, Masters KS,. The haemocompatibility of polyurethane-hyaluronic acid copolymers. Biomaterials 2008; 29 (2): 150-160.
37. Sundstrom C, Nilsson K,. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer 1976; 17 (5): 565-577.
38. Li WJ, Tuan RS,. Fabrication and application of nanofibrous scaffolds in tissue engineering. Curr Protoc Cell Biol 2009;Chapter 25:Unit 25 2.
39. Braet F, De Zanger R, Wisse E,. Drying cells for SEM, AFM and TEM by hexamethyldisilazane: A study on hepatic endothelial cells. J Microsc 1997; 186 (Pt 1): 84-87.
40. National Institutes of Health. In Vitro Cytotoxicity Test Methods for Estimating Acute Oral Systemic Toxicity. Vol. 2012. Research Triangle Park, NC: National Institutes of Health; 2002.
41. Patrice T, Harb J, Foultier MT, Berrada A, Robillard N, Galmiche JP, Meflah K, Lebodic L,. Endothelial cell growth regulation by PGE1 analog misoprostol and indomethacin. Dig Dis Sci 1989; 34 (11): 1681-1685.
42. Bisharat N, Minuhin I,. Prosthetic vascular graft infections between blood and concordance of graft culture pathogen. Am J Med Sci 2012.
43. Laser A, Baker N, Rectenwald J, Eliason JL, Criado-Pallares E, Upchurch GR Jr,. Graft infection after endovascular abdominal aortic aneurysm repair. J Vasc Surg 2011; 54 (1): 58-63.
44. Bisdas T, Beckmann E, Marsch G, Burgwitz K, Wilhelmi M, Kuehn C, Haverich A, Teebken OE,. Prevention of vascular graft infections with antibiotic graft impregnation prior to implantation: In vitro comparison between daptomycin, rifampin and nebacetin. Eur J Vasc Endovasc Surg 2012.
45. Ambrosio L, Borzacchiello A, Netti PA, Nicolais L,. Rheological study on hyaluronic acid and its derivative solutions. J Macromol Sci: Pure Appl Chem 1999; A36 (7-8): 991-1000.
46. Soletti L, Hong Y, Guan J, Stankus JJ, El-Kurdi MS, Wagner WR, Vorp DA,. A bilayered elastomeric scaffold for tissue engineering of small diameter vascular grafts. Acta Biomater 2010; 6 (1): 110-122.
47. Iwasaki K, Kojima K, Kodama S, Paz AC, Chambers M, Umezu M, Vacanti CA,. Bioengineered three-layered robust and elastic artery using hemodynamically- equivalent pulsatile bioreactor. Circulation 2008; 118 (14 Suppl): S52.
48. Baumgartner JN, Cooper SL,. Bacterial adhesion on polyurethane surfaces conditioned with thrombus components. ASAIO J 1996; 42 (5): M476-M479.
49. Liu WJ, Yang HL, Wang Z, Dong LS, Liu JJ,. Effect of nucleating agents on the crystallization of poly (3-hydroxybutyrate-co-3-hydroxyvalerate). J Appl Polym Sci 2002; 86 (9): 2145-2152.
50. Zeltsman D, Tzarnas CD, Kerstein MD,. Management of vascular prosthetic infections: Results of long-term follow-up. Am Surg 1999; 65 (4): 331-333.
51. DeRose G, Provan JL,. Infected arterial grafts: Clinical manifestations and surgical management. J Cardiovasc Surg (Torino) 1984; 25 (1): 51-57.
52. Carlson GA, Dragoo JL, Samimi B, Bruckner DA, Bernard GW, Hedrick M, Benhaim P,. Bacteriostatic properties of biomatrices against common orthopaedic pathogens. Biochem Biophys Res Commun 2004; 321 (2): 472-478.
53. Lee DG, Cho JJ, Park HK, Kim DK, Kim JI, Chang SG, Lee SJ,. Preventive effects of hyaluronic acid on Escherichia coli-induced urinary tract infection in rat. Urology 2010; 75 (4): 949-954.
54. Han DK, Park KD, Kim YH,. Sulfonated poly(ethylene oxide)-grafted polyurethane copolymer for biomedical applications. J Biomater Sci Polym Ed 1998; 9 (2): 163-174.
55. Ibrahim S, Ramamurthi A,. Hyaluronic acid cues for functional endothelialization of vascular constructs. J Tissue Eng Regen Med 2008; 2 (1): 22-32.
56. Joddar B, Ramamurthi A,. Fragment size- and dose-specific effects of hyaluronan on matrix synthesis by vascular smooth muscle cells. Biomaterials 2006; 27 (15): 2994-3004.
57. Shu XZ, Ghosh K, Liu Y, Palumbo FS, Luo Y, Clark RA, Prestwich GD,. Attachment and spreading of fibroblasts on an RGD peptide-modified injectable hyaluronan hydrogel. J Biomed Mater Res A 2004; 68 (2): 365-375.
58. Brigham MD, Bick A, Lo E, Bendali A, Burdick JA, Khademhosseini A,. Mechanically robust and bioadhesive collagen and photocrosslinkable hyaluronic acid semi-interpenetrating networks. Tissue Eng Part A 2009; 15 (7): 1645-1653.
59. Sheehan KM, DeLott LB, West RA, Bonnema JD, DeHeer DH,. Hyaluronic acid of high molecular weight inhibits proliferation and induces cell death in U937 macrophage cells. Life Sci 2004; 75 (26): 3087-3102.
60. Lanza RP, Langer R, Chick WL, Peppas NA,. Principles of Tissue Engineering. San Diego, CA: Academic Press; 1997.
61. Kim TG, Chung HJ, Park TG,. Macroporous and nanofibrous hyaluronic acid/collagen hybrid scaffold fabricated by concurrent electrospinning and deposition/leaching of salt particles. Acta Biomater 2008; 4 (6): 1611-1619.
62. Ji Y, Ghosh K, Shu XZ, Li B, Sokolov JC, Prestwich GD, Clark RAF, Rafailovich MH,. Electrospun three-dimensional hyaluronic acid nanofibrous scaffolds. Biomaterials 2006; 27 (20): 3782-3792.
63. Li J, He A, Han CC, Fang D, Hsiao BS, Chu B,. Electrospinning of hyaluronic acid (HA) and HA/gelatin blends. Macromol Rapid Commun 2005; 27 (2): 114-120.
64. Kou PM, Babensee JE,. Macrophage and dendritic cell phenotypic diversity in the context of biomaterials. J Biomed Mater Res A 2011; 96 (1): 239-260.
65. Liu R, Vang KZ, Kreeger PK, Gellman SH, Masters KS,. Experimental and computational analysis of cellular interactions with nylon-3-bearing substrates. J Biomed Mater Res A 2012; 100 (10): 2750-2759.
66. Roach P, Eglin D, Rohde K, Perry CC,. Modern biomaterials: A review-Bulk properties and implications of surface modifications. J Mater Sci Mater Med 2007; 18 (7): 1263-1277.